{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T16:11:36Z","timestamp":1725811896221},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s12471-010-0840-z","type":"journal-article","created":{"date-parts":[[2011,5,14]],"date-time":"2011-05-14T10:30:19Z","timestamp":1305369019000},"page":"592-597","source":"Crossref","is-referenced-by-count":9,"title":["A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI"],"prefix":"10.1007","volume":"18","author":[{"given":"A.A.C.M.","family":"Heestermans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Hermanides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.M.","family":"Gosselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.A.","family":"Hoorntje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Ottervanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-H.E.","family":"Dambrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kolkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.W.J.","family":"van \u2019t Hof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,15]]},"reference":[{"key":"840_CR1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","volume":"346","author":"GW Stone","year":"2002","unstructured":"Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957\u2013966.","journal-title":"N Engl J Med"},{"key":"840_CR2","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","volume":"293","author":"G Luca De","year":"2005","unstructured":"De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005;293:1759\u20131765.","journal-title":"JAMA"},{"key":"840_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ahj.2007.11.004","volume":"155","author":"MB Nienhuis","year":"2008","unstructured":"Nienhuis MB, Ottervanger JP, de Boer MJ, Dambrink JHE, Hoorntje JCA, Gosselink ATM, et al. Zwolle Myocardial Infarction Study Group. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am Heart J. 2008;155:673\u2013679.","journal-title":"Am Heart J"},{"key":"840_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","volume":"76","author":"JH Chesebro","year":"1987","unstructured":"Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76:142\u2013154.","journal-title":"Circulation"},{"key":"840_CR5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(08)61235-0","volume":"372","author":"AWJ \u2018t Hof van","year":"2008","unstructured":"van \u2018t Hof AWJ, ten Berg JM, Heestermans T, Dill T, Funck RC, van Werkum JW, et al. Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet. 2008;372:537\u2013546.","journal-title":"Lancet"},{"key":"840_CR6","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","volume":"29","author":"F Werf Van de","year":"2008","unstructured":"Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909\u20132945.","journal-title":"Eur Heart J"},{"key":"840_CR7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0002-8703(03)00509-X","volume":"146","author":"A Budaj","year":"2003","unstructured":"Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA, et al. GRACE Investigators. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2003;146:999\u20131006.","journal-title":"Am Heart J"},{"key":"840_CR8","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","volume":"27","author":"L Mandelzweig","year":"2006","unstructured":"Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Fillippatos G, et al. Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27:2285\u20132293.","journal-title":"Eur Heart J"},{"key":"840_CR9","unstructured":"ten Berg JM, van \u2018t Hof AWJ, Dill T, Heestermans T, van Werkum JW, Mosterd A, et al. on behalf of the Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Effect of Early, Pre-Hospital initiation of high-bolus dose tirofiban in patients with ST Elevation Myocardial Infarction on short and long-term clinical outcome. Accepted in JACC."},{"key":"840_CR10","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","volume":"358","author":"SG Ellis","year":"2008","unstructured":"Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, et al. FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358:2205\u20132217.","journal-title":"N Engl J Med"},{"key":"840_CR11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/hrt.2008.141648","volume":"94","author":"G Luca De","year":"2008","unstructured":"De Luca G, Gibson CM, Bellandi F, Murphy S, Maioli M, Noc M, et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart. 2008;94:1548\u2013558.","journal-title":"Heart"},{"key":"840_CR12","first-page":"33","volume":"1","author":"P Ortolani","year":"2009","unstructured":"Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, et al. Long-term effectiveness of early administration of glycoprotein IIb\/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J. 2009;1:33\u201343.","journal-title":"Eur Heart J"},{"key":"840_CR13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4244\/EIJV4I5A110","volume":"4","author":"AK Hassan","year":"2009","unstructured":"Hassan AK, Jukema JW, van der Laarse A, Hasan-Ali H, Wolterbeek R, van der Kley F, et al. Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment. EuroIntervention. 2009;4:662\u2013668.","journal-title":"EuroIntervention"},{"key":"840_CR14","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/j.1538-7836.2009.03573.x","volume":"7","author":"AA Heestermans","year":"2009","unstructured":"Heestermans AA, Van Werkum JW, Hamm C, Dill T, Gosselink ATM, De Boer MJ, et al. Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction. J Thromb Haemost. 2009;7:1612\u20131618.","journal-title":"J Thromb Haemost"},{"key":"840_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","volume":"348","author":"E Boersma","year":"1996","unstructured":"Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771\u2013775.","journal-title":"Lancet"},{"key":"840_CR16","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","volume":"358","author":"GW Stone","year":"2008","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al. HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218\u20132230.","journal-title":"N Engl J Med"},{"key":"840_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/eurheartj\/ehp376","volume":"31","author":"M Valgimigli","year":"2010","unstructured":"Valgimigli M, Biondi-Zoccai G, Tebaldi M, van \u2018t Hof AW, Campo G, Hamm C, et al. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J. 2010;31:35\u201349.","journal-title":"Eur Heart J"},{"key":"840_CR18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.thromres.2008.01.021","volume":"122","author":"AA Heestermans","year":"2008","unstructured":"Heestermans AA, van Werkum JW, Taubert D, Seesing TH, von Beckerath N, Hackeng CM, et al. Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction. Thromb Res. 2008;122:776\u2013781.","journal-title":"Thromb Res"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-010-0840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-010-0840-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-010-0840-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:16:22Z","timestamp":1559474182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-010-0840-z"}},"subtitle":["Insights from the Zwolle acute myocardial infarction registry"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1007\/s12471-010-0840-z","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}